Full-Time

VP – Search and Evaluation

Confirmed live in the last 24 hours

Formation Bio

Formation Bio

51-200 employees

Accelerates drug development using AI technology

AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$305k - $380kAnnually

+ Equity + Generous Perks

Senior, Expert

Boston, MA, USA + 1 more

More locations: New York, NY, USA

Hybrid position.

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD preferred (in a relevant field such as biology, chemistry, pharmacology, etc.)
  • Senior industry leader with 10+ years of experience in drug acquisition and deal-making
  • A proven track record of identifying and successfully in-licensing assets that have progressed to clinical development or approval
  • Extensive exposure to the drug development process from discovery through to clinical development, including knowledge of regulatory, scientific, and commercial aspects of drug development
  • Deep relationships across the pharmaceutical and biotech industries, with a strong network to identify innovative partnership opportunities
  • Leadership experience in a biotech or smaller company, with a deep understanding of the unique challenges and opportunities in these environments
  • Strategic mindset with the ability to think long-term and align in-licensing activities with the company’s overall business goals
Responsibilities
  • Overseeing the search and evaluation process to identify potential deals for in-licensing, including scouting and assessing external innovation
  • Guiding in-licensing strategy, including therapeutic area focus, modality, and stage of drug development to align with Formation Bio’s goals
  • Building and maintaining relationships with academic institutions, biotech, and large pharma partners to identify and advance potential opportunities
  • Leading and setting the diligence process, including defining scope, parameters, and evaluation criteria
  • Collaborating closely with internal stakeholders (scientific, commercial, legal, etc.) to ensure cross-functional input during diligence and decision-making
  • Delivering fully vetted, high-potential deals to the transactions team for negotiation and execution
  • Representing Formation Bio externally at conferences, industry events, and in key partner discussions to strengthen the company’s visibility and deal-making network
  • Staying ahead of emerging trends in drug development, scientific breakthroughs, and partnership models to position Formation Bio as a leader in deal execution and innovation
  • Leading, mentoring, and managing the Search and Evaluation team
  • Fostering a high-performance culture, ensuring alignment with organizational goals, and providing strategic guidance to team members in scouting, evaluating, and advancing potential opportunities

Formation Bio focuses on speeding up the process of developing new drugs by using its own AI-driven platform. This platform helps the company identify and acquire clinical-stage assets, which are drugs that are already in testing phases. By using flexible financing options, Formation Bio aims to lower the high costs and long timelines usually involved in drug development, making new treatments more accessible and affordable for patients. The company works with pharmaceutical and biotech firms to help them improve their drug development processes. What sets Formation Bio apart from its competitors is its emphasis on using advanced AI tools to enhance the selection and development of drugs, with the goal of successfully bringing these drugs to market and forming partnerships that generate revenue.

Company Stage

Series D

Total Funding

$515.8M

Headquarters

New York City, New York

Founded

N/A

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

3%

2 year growth

14%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $372M Series D funding will significantly bolster Formation Bio's expansion and product development efforts.
  • Collaborations with industry leaders like Sanofi and OpenAI could revolutionize drug discovery and development, enhancing the company's market position.
  • Formation Bio's innovative approach to clinical trials promises more efficient and faster drug development, potentially leading to quicker market entry and higher revenue.

What critics are saying

  • The high dependency on AI and technology platforms may pose risks if these technologies fail to deliver as expected.
  • The competitive nature of the pharmaceutical industry means that Formation Bio must continuously innovate to maintain its edge.

What makes Formation Bio unique

  • Formation Bio leverages a tech-driven platform to optimize clinical drug development, unlike traditional pharmaceutical companies that rely on conventional methods.
  • Their strategic partnerships with AI leaders like OpenAI and pharmaceutical giants such as Sanofi set them apart in the competitive landscape.
  • Formation Bio's focus on acquiring and accelerating the development of clinical-stage drugs enables faster access to new treatments for patients.

Help us improve and share your feedback! Did you find this helpful?